Role of Liver Stellate Cells
Hepatic stellate cells (HSCs) are the primary collagen-producing cells in the injured liver and serve as the main drivers of liver fibrosis, while also functioning as vitamin A storage cells and regulators of liver homeostasis in the healthy liver. 1
Primary Functions in Health and Disease
In the Healthy Liver (Quiescent State)
- Vitamin A storage: HSCs are the major vitamin A-storing cells of the liver, maintaining retinoid reserves 2, 3
- Homeostatic regulation: They play crucial roles in liver development, regeneration, and tissue homeostasis 2
- Hepatocyte proliferation: HSCs stimulate midzonal hepatocyte proliferation through secretion of growth factors like neurotrophin-3 4
- ECM stability: They maintain normal extracellular matrix balance in the space of Disse (located between liver sinusoidal endothelial cells and hepatocytes) 3
In Liver Injury (Activated State)
HSCs are the main producers of collagen in the injured liver and undergo transformation into matrix-producing myofibroblasts. 1 This activation process is central to liver fibrosis pathogenesis across all forms of chronic liver injury.
Activation Mechanisms
HSCs are activated by multiple stimuli 1:
- Direct activation: Alcohol metabolites (acetaldehyde) directly activate HSCs
- Indirect activation: Injured hepatocytes, activated Kupffer cells, and infiltrating polymorphonuclear leukocytes trigger HSC activation
- Signaling pathways: Oxygen free radicals stimulate intracellular pathways including extracellular signal-regulated kinase, PI3K/Akt, and JNK 1
Fibrogenic Activities
Once activated, HSCs 1:
- Produce excessive collagen and other extracellular matrix proteins
- Secrete pro-fibrotic growth factors: TGF-β1, PDGF
- Release pro-inflammatory cytokines: leptin, angiotensin II, IL-8, TNF-α
- Generate soluble mediators: nitric oxide and oxygen free radicals
- Enhance matrix accumulation: Oxygen free radicals increase tissue inhibitor of metalloproteinase 1 activity, reducing metalloproteinase function and promoting collagen accumulation 1
Cellular Heterogeneity
HSCs are not a single uniform population but rather comprise heterogeneous subsets with differentiated and specific functions. 5 Recent single-cell RNA sequencing studies have identified unique HSC populations with diverse phenotypic alterations during activation 2.
Major Sources of Myofibroblasts
While HSCs represent the major source of myofibroblasts in the injured liver 6, other contributors include:
Role in Fibrosis Regression
HSCs can revert to an inactive phenotype during fibrosis resolution, though this state differs from their original quiescent form. 6 Key points:
- Reverted HSCs remain "primed" for re-activation if re-injury occurs 6
- This bidirectional capacity makes HSCs both drivers of fibrosis progression and potential mediators of resolution
- The balance between matrix deposition and clearance involves HSC-regulated factors including MMPs and TIMPs 6
Therapeutic Implications
HSCs have emerged as the primary cellular target for anti-fibrotic therapies. 7, 6 Targeting strategies include:
- Promoting HSC apoptosis or inactivation
- Inducing HSC senescence
- Blocking activation pathways: TGF-β, PDGF, Wnt/β-catenin signaling 8
- Epigenetic interventions: DNA methylation, histone modification, non-coding RNA modulation 9
- Autophagy-dependent ferroptosis: RNA-binding proteins like ZFP36 and ELAVL1 regulate ferroptosis in HSCs, affecting fibrosis progression 7
Clinical Context
Understanding HSC biology is critical because:
- Fibrosis stage determines prognosis in chronic liver disease 10
- HSC activation precedes cirrhosis: Collagen band formation and bridging fibrosis develop before regeneration nodules form 1
- Dual nature: HSCs function as both pathogenic drivers of fibrosis and potential mediators of liver regeneration 5, requiring careful consideration when developing targeted therapies
The recognition that HSCs serve both beneficial (homeostatic, regenerative) and detrimental (fibrogenic) roles emphasizes the need for precision in therapeutic targeting—inhibiting pathological fibrosis while preserving regenerative capacity.